Article ID Journal Published Year Pages File Type
2575735 The American Journal of Geriatric Pharmacotherapy 2012 14 Pages PDF
Abstract
The similar and low rates of AEs in DSG-treated patients aged ≥65 years and <65 years and in those with and without comorbid hypertension, type 2 diabetes, or cerebrovascular or cardiovascular disease suggest that DSG treatment is generally well tolerated.
Related Topics
Health Sciences Medicine and Dentistry Geriatrics and Gerontology
Authors
, , , ,